Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis

Ford, 2002, Prevalence of the metabolic syndrome among US adults, JAMA, 287, 356, 10.1001/jama.287.3.356 Sinha, 2002, Prevalence of impaired glucose tolerance among children and adolescents with marked obesity, N Engl J Med, 346, 802, 10.1056/NEJMoa012578 Matteoni, 1999, Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity, Gastroenterology, 116, 1413, 10.1016/S0016-5085(99)70506-8 Angulo, 2002, Nonalcoholic fatty liver disease, N Engl J Med, 346, 1221, 10.1056/NEJMra011775 Valenti, 2002, Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease, Gastroenterology, 122, 274, 10.1053/gast.2002.31065 Friedman, 2000, Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury, J Biol Chem, 275, 2247, 10.1074/jbc.275.4.2247 Dufour, 1997, Reversibility of hepatic fibrosis in autoimmune hepatitis, Ann Intern Med, 127, 981, 10.7326/0003-4819-127-11-199712010-00006 Arthur, 2002, Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C, Gastroenterology, 122, 1525, 10.1053/gast.2002.33367 Reid, 2001, Nonalcoholic steatohepatitis, Gastroenterology, 121, 710, 10.1053/gast.2001.27126 Hruszkewycz, 1998, Evidence for mitochondrial DNA damage by lipid peroxidation, Biochem Biophys Res Commun, 153, 191, 10.1016/S0006-291X(88)81207-5 Visser, 1999, Elevated C-reactive protein levels in overweight and obese adults, JAMA, 282, 2131, 10.1001/jama.282.22.2131 Ford, 2001, C-reactive protein and body mass index in children: findings from the third national health and nutrition examination survey, 1988-1994, J Pediatr, 138, 486, 10.1067/mpd.2001.112898 van Dielen, 2001, Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals, Int J Obes, 25, 1759, 10.1038/sj.ijo.0801825 Sanyal, 2001, Nonalcoholic steatohepatitis : association of insulin resistance and mitochondrial abnormalities, Gastroenterology, 120, 1183, 10.1053/gast.2001.23256 Kaplan, 1998, Leptin, obesity, and liver disease, Gastroenterology, 115, 997, 10.1016/S0016-5085(98)70272-0 Yang, 2001, Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition?, Cancer Res, 61, 5016 Kral, 2001, Morbidity of severe obesity, Surg Clin North Am, 81, 1039, 10.1016/S0039-6109(05)70183-3 Marceau, 1999, Liver pathology and the metabolic syndrome X in severe obesity, J Clin Endocrinol Metab, 84, 1513, 10.1210/jc.84.5.1513 Torjesen, 1997, Lifestyle changes may reverse development of the insulin resistance syndrome, Diabetes Care, 20, 26, 10.2337/diacare.20.1.26 Tchernof, 2002, Weight loss reduces C-reactive protein levels in obese postmenopausal women, Circulation, 105, 564, 10.1161/hc0502.103331 Knobler, 1999, Fatty liver—an additional and treatable feature of the insulin resistance syndrome, QJM, 92, 73, 10.1093/qjmed/92.2.73 Tilg, 2003, Cytokines in alcoholic and nonalcoholic steatohepatitis, N Engl J Med, 343, 1467, 10.1056/NEJM200011163432007 MacDonald, 1997, The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus, J Gastro Surg, 1, 213, 10.1016/S1091-255X(97)80112-6 Scopinaro, 1996, Biliopancreatic diversion for obesity at eighteen years, Surgery, 119, 261, 10.1016/S0039-6060(96)80111-5 Lowell, 1997, Liver transplantation after jejunoileal bypass for morbid obesity, J Am Coll Surg, 185, 123, 10.1016/S1072-7515(01)00894-8 Hocking, 1998, Long-term consequences after jejunoileal bypass for morbid obesity, Dig Dis Sci, 43, 2493, 10.1023/A:1026698602714 Grimm, 1992, Steatohepatitis and fatal hepatic failure after biliopancreatic diversion, Am J Gastro, 87, 775 Hamilton, 1983, Liver injury with alcoholic-like hyaline after gastroplasty for morbid obesity, Gastroenterology, 85, 722, 10.1016/0016-5085(83)90032-X Capron, 1982, Fasting in obesity. Another cause of liver injury with alcoholic hyaline?, Dig Dis Sci, 27, 265, 10.1007/BF01296926 Angulo, 1999, Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis, Hepatology, 30, 1356, 10.1002/hep.510300604 Ratziu, 2000, Liver fibrosis in overweight patients, Gastroenterology, 118, 1117, 10.1016/S0016-5085(00)70364-7 Dixon, 2001, Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese, Gastroenterology, 121, 91, 10.1053/gast.2001.25540 Clark, 2002, Nonalcoholic fatty liver disease, Gastroentology, 122, 1649, 10.1053/gast.2002.33573 Baldridge, 1995, Idiopathic steatohepatitis in childhood: a multicenter retrospective study, J Pediatr, 127, 700, 10.1016/S0022-3476(95)70156-7 Bravo, 2001, Liver biopsy, N Engl J Med, 334, 495, 10.1056/NEJM200102153440706 Pratt, 2000, Evaluation of abnormal liver-enzyme results in asymptomatic patients, N Engl J Med, 342, 1266, 10.1056/NEJM200004273421707 Marceau, 2001, Malabsorptive obesity surgery, Obes Surg, 81, 1113 Marceau, 1995, Biliopancreatic diversion with distal gastrectomy, 250 cm and 50 cm limbs: long-term results, Obes Surg, 5, 302, 10.1381/096089295765557683 Lieber, 1994, Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon, Gastroenterology, 106, 152, 10.1016/S0016-5085(94)95023-7 Bowker, 1948, Bowker's test of symmetry, J Am Statistical Assoc, 43, 572, 10.2307/2280710 Ferrannini, 2000, Insulin resistance, iron and the liver, Lancet, 355, 2181, 10.1016/S0140-6736(00)02397-7 Kral, 1993, Body fat topography as an independent predictor of fatty liver, Metabolism, 42, 548, 10.1016/0026-0495(93)90210-F Marchesini, 1999, Association of non-alcoholic fatty liver disease with insulin resistance, Am J Med, 107, 450, 10.1016/S0002-9343(99)00271-5 Cortez-Pinto, 1999, Non-alcoholic fatty liver: another feature of the metabolic syndrome?, Clin Nutr, 18, 353, 10.1016/S0261-5614(99)80015-6 Luyckx, 2000, Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss, Diabetes Metab, 26, 98 Silverman, 1995, Regression of hepatic steatosis in morbidly obese persons after gastric bypass, Am J Clin Pathol, 104, 23, 10.1093/ajcp/104.1.23 Brolin, 1998, Unsuspected cirrhosis discovered during elective obesity operations, Arch Surg, 133, 84, 10.1001/archsurg.133.1.84 Soyer, 1976, Reversibility of severe hepatic damage caused by jejunoileal bypass after re-establishment of normal intestinal continuity, Surgery, 79, 601 Styblo, 1984, The effects of reversal of jejunoileal bypass operations on hepatic triglycerides content and hepatic morphology, Surgery, 96, 632 Hammel, 2001, Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct, N Engl J Med, 344, 418, 10.1056/NEJM200102083440604 Kral, 2001, Metabolic correlates of eating behavior in severe obesity, Int J Obes Relat Metab Disord, 25, 258, 10.1038/sj.ijo.0801469 Kral, 1977, Hepatic lipid metabolism in severe human obesity, Metabolism, 26, 1025, 10.1016/0026-0495(77)90020-8 Poy, 2002, CEACAM1 regulates insulin clearance in liver, Nat Genet, 30, 270, 10.1038/ng840 Rosmond, 2000, A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis, Obes Res, 8, 211, 10.1038/oby.2000.24 Gohil, 2001, Hypothalamic-pituitary-adrenal axis function and the metabolic syndrome X of obesity, CNS Spectrums, 6, 581, 10.1017/S1092852900002121 Chrousos, 1995, The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation, N Engl J Med, 332, 1351, 10.1056/NEJM199505183322008 Dubuisson, 2002, Inhibition of rat liver fibrogenesis through noradrenergic antagonism, Hepatology, 35, 325, 10.1053/jhep.2002.31166 Shuldiner, 2001, Resistin, obesity, and insulin resistance—the emerging role of the adipocyte as an endocrine organ, N Engl J Med, 345, 1345, 10.1056/NEJM200111013451814 Ikejima, 2002, Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat, Gastroenterology, 122, 1399, 10.1053/gast.2002.32995 Marra, 2002, Leptin and liver fibrosis: a matter of fat, Gastroenterology, 122, 1529, 10.1053/gast.2002.33369 Saxena, 2002, Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice, Hepatology, 35, 762, 10.1053/jhep.2002.32029 Day, 1998, Steatohepatitis: a tale of two “hits”?, Gastroenterology, 114, 842, 10.1016/S0016-5085(98)70599-2 Fogel, 1976, Absorptive and digestive function of the jejunum after jejunoileal bypass for treatment of human obesity, Gastroenterology, 71, 729, 10.1016/S0016-5085(76)80351-4 Drenick, 1982, Hepatic steatosis after intestinal bypass—prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition, Gastroenterology, 82, 535, 10.1016/S0016-5085(82)80403-4 Savolainen, 1993, Alcohol consumption and alcoholic liver disease: evidence of a threshold level of effects of ethanol<40 g daily x 25 yrs, Alcohol Clin Exp Res, 17, 1112, 10.1111/j.1530-0277.1993.tb05673.x Dixon, 2002, Alcohol consumption in the severely obese: relationship with the metabolic syndrome, Obes Res, 10, 245, 10.1038/oby.2002.33 Brenner, 2000, Moderate alcohol drinking: effects on the heart and liver, Gastroenterology, 119, 1399, 10.1053/gast.2000.20206 Raynard, 2002, Risk factors of fibrosis in alcohol-induced liver disease, Heptatology, 35, 635, 10.1053/jhep.2002.31782 Clark, 2003, Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis, JAMA, 289, 3000, 10.1001/jama.289.22.3000